» Articles » PMID: 34200322

A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jul 2
PMID 34200322
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A novel bioluminescent Monoacylglycerol lipase (MAGL) substrate 6-O-arachidonoylluciferin, a D-luciferin derivative, was synthesized, physico-chemically characterized, and used as highly sensitive substrate for MAGL in an assay developed for this purpose. We present here a new method based on the enzymatic cleavage of arachidonic acid with luciferin release using human Monoacylglycerol lipase (MAGL) followed by its reaction with a chimeric luciferase, PLG2, to produce bioluminescence. Enzymatic cleavage of the new substrate by MAGL was demonstrated, and kinetic constants Km and Vmax were determined. 6-O-arachidonoylluciferin has proved to be a highly sensitive substrate for MAGL. The bioluminescence assay (LOD 90 pM, LOQ 300 pM) is much more sensitive and should suffer fewer biological interferences in cells lysate applications than typical fluorometric methods. The assay was validated for the identification and characterization of MAGL modulators using the well-known MAGL inhibitor JZL184. The use of PLG2 displaying distinct bioluminescence color and kinetics may offer a highly desirable opportunity to extend the range of applications to cell-based assays.

Citing Articles

Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes.

Ciuffreda P, Xynomilakis O, Casati S, Ottria R Int J Mol Sci. 2024; 25(14).

PMID: 39062935 PMC: 11276806. DOI: 10.3390/ijms25147693.


Advances in luminescence-based technologies for drug discovery.

Baljinnyam B, Ronzetti M, Simeonov A Expert Opin Drug Discov. 2022; 18(1):25-35.

PMID: 36562206 PMC: 9892298. DOI: 10.1080/17460441.2023.2160441.


Activity-based Photoacoustic Probes Reveal Elevated Intestinal MGL and FAAH Activity in a Murine Model of Obesity.

Lucero M, Gardner S, Yadav A, Borri A, Zhao Z, Chan J Angew Chem Int Ed Engl. 2022; 61(44):e202211774.

PMID: 36083191 PMC: 9613605. DOI: 10.1002/anie.202211774.


Small-Molecules as Chemiluminescent Probes to Detect Lipase Activity.

La Rocca P, Mingione A, Casati S, Ottria R, Allevi P, Ciuffreda P Int J Mol Sci. 2022; 23(16).

PMID: 36012304 PMC: 9409280. DOI: 10.3390/ijms23169039.

References
1.
Mulvihill M, Nomura D . Therapeutic potential of monoacylglycerol lipase inhibitors. Life Sci. 2012; 92(8-9):492-7. PMC: 3594462. DOI: 10.1016/j.lfs.2012.10.025. View

2.
Laezza C, Pagano C, Navarra G, Pastorino O, Proto M, Fiore D . The Endocannabinoid System: A Target for Cancer Treatment. Int J Mol Sci. 2020; 21(3). PMC: 7037210. DOI: 10.3390/ijms21030747. View

3.
Malamas M, Farah S, Lamani M, Pelekoudas D, Perry N, Rajarshi G . Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors. Bioorg Med Chem. 2019; 28(1):115195. DOI: 10.1016/j.bmc.2019.115195. View

4.
McCaffrey A, Kay M, Contag C . Advancing molecular therapies through in vivo bioluminescent imaging. Mol Imaging. 2003; 2(2):75-86. DOI: 10.1162/15353500200303124. View

5.
Cristino L, Bisogno T, Di Marzo V . Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2019; 16(1):9-29. DOI: 10.1038/s41582-019-0284-z. View